The Registrar of Companies approved the change of name from Merck Limited to Procter & Gamble Health Limited, effective 6 May
The decision to change the name of the listed entity in India follows the completion of P&G’s global acquisition of consumer health business of Merck KGaA, Darmstadt, Germany
New Delhi: Global personal healthcare leader Procter and Gamble on Tuesday announced renaming of Merck Ltd as Procter & Gamble Health Limited, following P&G’s global acquisition of the consumer health business of Merck KGaA.
The company received an approval from the Registrar of Companies for change of name from Merck Limited to Procter & Gamble Health Limited, effective 6 May, the company said in a statement.
“Today marks the beginning of an exciting new era for Procter & Gamble Health Limited (formerly Merck Limited), one of India’s largest consumer health companies. Our new name reflects our new identity as part of the P&G group and signifies the coming together of strong consumer health capabilities and cultures. Together, we are working towards leveraging our combined expertise to develop categories and brands that meet today’s needs and tomorrow’s opportunities," said Milind Thatte, Managing Director, Procter & Gamble Health Limited, in a statement,
The decision to change the name of the listed entity in India follows the successful completion of P&G’s global acquisition of the consumer health business of Merck KGaA, Darmstadt, Germany. The consumer health business was transferred to P&G on 1 December 2018.
Tom Finn, President, Global Personal Health Care, Procter & Gamble said “I am delighted to announce the new name of our listed entity which will now be known as Procter & Gamble Health Limited. With India’s OTC market growing at double the global growth rate, this is a very exciting phase for all of us as we now move forward to realize the great potential of our two health-related P&G businesses in India."
Procter & Gamble Health Limited will be a part of P&G’s Personal Health Care International Business Unit led by Uta Kemmerich-Keil, Vice President, Personal Health Care International, that encompasses the company’s health care businesses in Europe, Latin America, and Asia/IMEA (India, Middle East and Africa).
“We are extremely pleased with this development. With our strong portfolio of brands that are backed by science and trusted by doctors, pharmacists and consumers, we believe that we are well-positioned to enable consumers in India to live longer, healthier and more vibrant lives," said Uta Kemmerich-Keil.